Novartis Oncology discovers and develops innovative products to treat patients with cancer, and hematologic, and rare diseases. Novartis is committed to the advancement of these goals through professional education.
The Novartis Oncology Office of Grants and Education (OGE) supports independent accredited and nonaccredited medical education programs intended to provide nonpromotional, current scientific information to US health care professionals and to improve patient care. Supported programs must be compliant with all applicable legal and regulatory guidelines, and be consistent with federal laws and regulations and the ethical standards under which Novartis Pharmaceuticals Corporation (NPC) conducts business. Funding may never be linked to prescribing, purchasing, formulary status, or reimbursement activities.
For more information on the grants process or to submit an educational grant request, please visit the Novartis Grants Central Station website at http://ngcs.novartis.com/.
Oncology Grants and Education